Lost Women of Science

When Dr. Dorothy Andersen confronted a slew of confounding infant deaths, she suspected the accepted diagnosis wasn’t right. Her medical sleuthing led to the world’s understanding of cystic fibrosis, a disease that affects the lungs, the pancreas, and a host of other organs. But hers is by no means a household name. Who was this scientist, and how did she come to quietly make such an important medical contribution?
Access a transcript of the episode here: https://www.scientificamerican.com/article/the-lost-women-of-science-episode-1-the-question-mark/

Sara Little Turnbull was a force in the world of material science and industrial design. It’s safe to say most people will have used something that started life on her drawing board, but few will know her name. She worked with engineered fabrics at 3M, designing a moldable bra cup that inspired the design of the N95 mask. Later 3M disputed her role in coming up with the mask. She also worked on clear glass cooktop development, the early microwave, storage systems, and many other products.

In 1949, at the height of his career, Rustin McIntosh, the director of pediatrics at Columbia University’s Babies Hospital, submitted his letter of resignation. Dr. Scott Baird, who wrote a biography on Dorothy Andersen, takes us back to this pivotal moment, which occurred at the dawn of pediatric pathology in the United States. Through archival resources, Scott explores the institutional tensions that led to this abrupt resignation. At the eye of the storm is a character we’ve come to know well, perhaps the most important person working in pediatric pathology at the time: Dr. Dorothy Andersen.

Access a transcript of the episode here: https://www.scientificamerican.com/article/lost-women-of-science-podcast-bonus-episode-the-resignation/

It’s the early 1960s and the German pharmaceutical market is booming. A sedative called Contergan is one of the bestselling drugs. Contergan’s active ingredient is thalidomide and it is touted as a wonder drug, a non-addictive sedative safer than barbiturates. In the U.S., the drug is called Kevadon, and its distributor is impatient to get the drug on the market. But Dr. Frances Kelsey, a medical examiner at the U.S. Food and Drug Administration, is stalling the approval of Kevadon. She wants more information from the manufacturer to prove it is safe. Meanwhile, doctors in Scotland and Australia are beginning to suspect thalidomide might, in fact, be very toxic. And in Germany, reports are beginning to emerge of a mysterious epidemic of babies born with missing limbs and other serious medical conditions, but doctors have no idea what's causing it.

In our final episode, we explore Dorothy Andersen’s legacy—what she left behind and how her work has lived on since her death. Describing her mentor’s influence on her life and career, Dr. Celia Ores gives us a rare look into what Dr. Andersen was really like. We then turn to researchers, doctors, and patients, who fill us in on the progress that has grown from Dr. Andersen’s initial work. These major developments include the discovery of the cystic fibrosis gene, the tremendous impact of the drug Trikafta, and the lifesaving potential of gene editing techniques.

Access a transcript of the episode here: https://www.scientificamerican.com/article/lost-women-of-science-episode-4-breakfast-in-the-snow/